A major new study reveals that older adults with cancer and type 2 diabetes who take GLP-1 receptor agonist medications (GLP-1RAs) experience significantly better overall survival rates compared to ...

A new umbrella review reveals how GLP-1 therapies shape cardiovascular, renal, and metabolic outcomes in type 2 diabetes while highlighting drug-specific advantages and the need to manage ...

The potential benefits of GLP-1 medications continue to expand. New research has found that the weight loss and diabetes drugs — officially known as glucagon-like peptide 1 receptor agonists — are ...

GLP-1 drugs have helped people successfully achieve and maintain weight loss; however, losing muscle has been a significant concern. New research suggests that weight loss treatments using GLP-1 and ...

New research reveals that young adults with higher body shame and weight concerns are more likely to consider GLP-1 medications, despite significant side effects, unless buffered by strong body ...

A new study from researchers at Cambridge, Mass.-based Harvard University found that blockbuster GLP-1 drugs such as Ozempic and Zepbound may have a minimal effect on an individual’s risk of ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat obesity. Iuliia Burmistrova/Getty Images GLP-1 drugs have helped people successfully achieve and ...